Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 9;23(3):243-5.
doi: 10.1128/CVI.00590-15.

Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels

Affiliations

Mucosal IgG Levels Correlate Better with Respiratory Syncytial Virus Load and Inflammation than Plasma IgG Levels

Marloes Vissers et al. Clin Vaccine Immunol. .

Abstract

Maternal vaccination is currently considered a strategy against respiratory syncytial virus (RSV) infections. In RSV-infected infants, high mucosal IgG levels correlated better with reduced RSV load and lower mucosal CXCL10 levels than plasma IgG levels. For future vaccination strategies against RSV, more focus should be on the mucosal humoral immune response.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Mucosal IgG levels correlate better with respiratory syncytial virus load than plasma IgG levels. Mucosal and plasma samples were taken from RSV-infected infants. Viral load, mucosal and plasma IgG levels, and mucosal and plasma CXCL10 levels were determined. Correlation analyses were performed using a Pearson correlation test. GraphPad Prism 5.03 was used for statistics (GraphPad Software). P values of <0.05 were considered statistically significant. (A) Mucosal and plasma IgG levels were not correlated. (B) Viral load was negatively correlated with mucosal IgG levels but not with plasma IgG levels. (C) Viral load is positively correlated with CXCL10 levels in the nose but not in plasma. (D) Finally, mucosal CXCL10 levels were negatively correlated with mucosal IgG levels but not plasma IgG levels.

Comment in

References

    1. Blount RE Jr, Morris JA, Savage RE. 1956. Recovery of cytopathogenic agent from chimpanzees with goryza. Proc Soc Exp Biol Med 92:544–549. doi:10.3181/00379727-92-22538. - DOI - PubMed
    1. Chanock RM. 1956. Association of a new type of cytopathogenic myxovirus with infantile croup. J Exp Med 104:555–576. doi:10.1084/jem.104.4.555. - DOI - PMC - PubMed
    1. The IMpact-RSV Study Group. 1998. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 102:531–537. doi:10.1542/peds.102.3.531. - DOI - PubMed
    1. Reference deleted.
    1. Andabaka T, Nickerson JW, Rojas-Reyes MX, Rueda JD, Bacic Vrca V, Barsic B. 2013. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 4:CD006602. doi:10.1002/14651858.CD006602.pub4. - DOI - PubMed

Publication types

MeSH terms